Autologous stem cell transplantation (ASCT) with immunologically purged progenitor cells in patients with advanced stage follicular lymphoma after early partial or complete remission: toxicity, follow-up of minimal residual disease and survival

Follicular Lymphoma ◽

Progenitor Cells ◽

Residual Disease ◽

Advanced Stage ◽

Pretransplant Minimal Residual Disease (MRD) Positivity Independently Predicts Survival in a Unselected Cohort of Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2014.11.179 ◽

2015 ◽

Vol 21 (2) ◽

pp. S131-S132

Author(s):

Andrew J. Cowan ◽

Philip A. Stevenson ◽

Ryan D. Cassaday ◽

Solomon A. Graf ◽

Leona Holmberg ◽

...

Keyword(s):

Stem Cell ◽

Complete Remission ◽

Mantle Cell Lymphoma ◽

Residual Disease ◽

Cell Lymphoma ◽

Mantle Cell ◽

Minimal Residual ◽

Unselected Cohort

Pretransplantation Minimal Residual Disease Predicts Survival in Patients with Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2015.08.035 ◽

2016 ◽

Vol 22 (2) ◽

pp. 380-385 ◽

Cited By ~ 21

Author(s):

Andrew J. Cowan ◽

Philip A. Stevenson ◽

Ryan D. Cassaday ◽

Solomon A. Graf ◽

Jonathan R. Fromm ◽

...

Keyword(s):

Stem Cell ◽

Complete Remission ◽

Mantle Cell Lymphoma ◽

Autologous Stem Cell Transplantation ◽

Residual Disease ◽

Cell Lymphoma ◽

Mantle Cell ◽

High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission

Leukemia Research ◽

10.1016/j.leukres.2017.10.010 ◽

2017 ◽

Vol 63 ◽

pp. 22-27 ◽

Cited By ~ 10

Author(s):

Anna Candoni ◽

Federico De Marchi ◽

Maria Elena Zannier ◽

Davide Lazzarotto ◽

Carla Filì ◽

...

Keyword(s):

Gene Expression ◽

Stem Cell ◽

Complete Remission ◽

Allogeneic Stem Cell Transplantation ◽

Prognostic Value ◽

Residual Disease ◽

Wt1 Gene ◽

Faculty Opinions recommendation of A 4-weekly course of rituximab is safe and improves tumor control for patients with minimal residual disease persisting 3 months after autologous hematopoietic stem-cell transplantation: results of a prospective multicenter phase II study in patients with follicular lymphoma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717952962.793459745 ◽

2012 ◽

Author(s):

Anskar YH Leung

Keyword(s):

Stem Cell ◽

Follicular Lymphoma ◽

Residual Disease ◽

Phase Ii Study ◽

Tumor Control ◽

Hematopoietic Stem ◽

Multicenter Phase ◽

Faculty Opinions recommendation of A 4-weekly course of rituximab is safe and improves tumor control for patients with minimal residual disease persisting 3 months after autologous hematopoietic stem-cell transplantation: results of a prospective multicenter phase II study in patients with follicular lymphoma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717952962.793458509 ◽

2012 ◽

Author(s):

Nelson Chao

Keyword(s):

Stem Cell ◽

Follicular Lymphoma ◽

Residual Disease ◽

Phase Ii Study ◽

Tumor Control ◽

Hematopoietic Stem ◽

Multicenter Phase ◽

A comparison of minimal residual disease detection in autografts among ASO-qPCR, droplet digital PCR, and next-generation sequencing in patients with multiple myeloma who underwent autologous stem cell transplantation

British Journal of Haematology ◽

10.1111/bjh.15002 ◽

2017 ◽

Vol 183 (4) ◽

pp. 664-668 ◽

Cited By ~ 5

Author(s):

Hiroyuki Takamatsu ◽

Rachel K. Wee ◽

Yoshitaka Zaimoku ◽

Ryoichi Murata ◽

Jianbiao Zheng ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Next Generation Sequencing ◽

Residual Disease ◽

Digital Pcr ◽

Droplet Digital Pcr ◽

Generation Sequencing ◽

The value of monitoring minimal residual disease in the patients with donor lymphocyte infusion as intervention of relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation

American Journal of Hematology ◽

10.1002/ajh.21573 ◽

2009 ◽

pp. NA-NA

Author(s):

Xiao Ma ◽

Depei Wu ◽

Aining Sun ◽

Huiying Qiu ◽

Zhenzhen Fu ◽

...

Keyword(s):

Stem Cell ◽

Acute Lymphoblastic Leukemia ◽

Residual Disease ◽

Lymphoblastic Leukemia ◽

Donor Lymphocyte Infusion ◽

Hematopoietic Stem ◽

Intensive monitoring of minimal residual disease and chimerism after allogeneic hematopoietic stem cell transplantation for acute leukemia in children

Bone Marrow Transplantation ◽

10.1038/s41409-021-01408-5 ◽

2021 ◽

Author(s):

Thomas Pincez ◽

Raoul Santiago ◽

Henrique Bittencourt ◽

Isabelle Louis ◽

Mélanie Bilodeau ◽

...

Keyword(s):

Stem Cell ◽

Acute Leukemia ◽

Residual Disease ◽

Hematopoietic Stem ◽

Intensive Monitoring ◽

Leukemia In Children ◽

Impact of pre-transplantation minimal residual disease determined by multiparameter flow cytometry on the outcome of AML patients with FLT3-ITD after allogeneic stem cell transplantation

Annals of Hematology ◽

10.1007/s00277-018-3265-1 ◽

2018 ◽

Vol 97 (6) ◽

pp. 967-975 ◽

Cited By ~ 10

Author(s):

Xiaosu Zhao ◽

Zhidong Wang ◽

Guorui Ruan ◽

Yanrong Liu ◽

Yu Wang ◽

...

Keyword(s):

Flow Cytometry ◽

Stem Cell ◽

Cell Transplantation ◽

Allogeneic Stem Cell Transplantation ◽

Residual Disease ◽

Multiparameter Flow Cytometry ◽

Minimal residual disease testing after stem cell transplantation for multiple myeloma

Bone Marrow Transplantation ◽

10.1038/bmt.2015.164 ◽

2015 ◽

Vol 51 (1) ◽

pp. 2-12 ◽

Cited By ~ 14

Author(s):

A M Sherrod ◽

P Hari ◽

C A Mosse ◽

R C Walker ◽

R F Cornell

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Cell Transplantation ◽

Residual Disease ◽

Minimal Residual ◽

Disease Testing